InsiderTrades

Form 4 for SRPT Sarepta Therapeutics, Inc.

Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001193125-26-089425 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-03 2026-03-02 SRPT Rodino-Klapac Louise Pres, R, D, Tech Ops F - Tax $16.20 -4,485 228.4K -2% -$72.7K
D 2026-03-03 2026-03-01 SRPT Rodino-Klapac Louise Pres, R, D, Tech Ops M - OptEx — +8,125 232.2K +4% —
D 2026-03-03 2026-03-01 SRPT Rodino-Klapac Louise Pres, R, D, Tech Ops M - OptEx $0.00 -8,125 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-02 F D 767 $16.20 227,670 D — —
2 Common Common Stock 2026-03-01 M A 8,125 — 232,155 D — — (F1) Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026.
3 Common Common Stock 2026-03-02 F D 3,718 $16.20 228,437 D — —
4 Derivative Performance Stock Units 2026-03-01 M D 8,125 $0.00 0 D — · — to — 8,125 Common Stock (F1) Represents the number of shares previously earned under a PSU award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The shares vested on March 1, 2026.